Table of Contents

company-logo

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.

Virios Therapeutics Dividend Announcement

• Virios Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Virios Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Virios Therapeutics Dividend History

Virios Therapeutics Dividend Yield

Virios Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Virios Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Virios Therapeutics Financial Ratios

P/E ratio-0.76
PEG ratio0.01
P/B ratio1.13
ROE-130.35%
Payout ratio0.00%
Current ratio7.27
Quick ratio7.27
Cash Ratio6.04

Virios Therapeutics Dividend FAQ

Does Virios Therapeutics stock pay dividends?
Virios Therapeutics does not currently pay dividends to its shareholders.
Has Virios Therapeutics ever paid a dividend?
No, Virios Therapeutics has no a history of paying dividends to its shareholders. Virios Therapeutics is not known for its dividend payments.
Why doesn't Virios Therapeutics pay dividends?
There are several potential reasons why Virios Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Virios Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Virios Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Virios Therapeutics a dividend aristocrat?
Virios Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Virios Therapeutics a dividend king?
Virios Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Virios Therapeutics a dividend stock?
No, Virios Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Virios Therapeutics stocks?
To buy Virios Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Virios Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.